CA2602693A1 - Probiotic bifidobacterial species - Google Patents
Probiotic bifidobacterial species Download PDFInfo
- Publication number
- CA2602693A1 CA2602693A1 CA002602693A CA2602693A CA2602693A1 CA 2602693 A1 CA2602693 A1 CA 2602693A1 CA 002602693 A CA002602693 A CA 002602693A CA 2602693 A CA2602693 A CA 2602693A CA 2602693 A1 CA2602693 A1 CA 2602693A1
- Authority
- CA
- Canada
- Prior art keywords
- bifidobacterium
- cncm
- bifidobacterium strain
- strain
- probiotic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000006041 probiotic Substances 0.000 title claims abstract 5
- 230000000529 probiotic effect Effects 0.000 title claims abstract 5
- 235000018291 probiotics Nutrition 0.000 title claims abstract 5
- 241001655328 Bifidobacteriales Species 0.000 title 1
- 241000186000 Bifidobacterium Species 0.000 claims abstract 11
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000000203 mixture Substances 0.000 claims abstract 5
- 244000005700 microbiome Species 0.000 claims abstract 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 238000011282 treatment Methods 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 235000014121 butter Nutrition 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 235000015140 cultured milk Nutrition 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 235000013618 yogurt Nutrition 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05104071 | 2005-05-16 | ||
| EP05104071.5 | 2005-05-16 | ||
| PCT/EP2006/061247 WO2006122850A1 (en) | 2005-05-16 | 2006-03-31 | Probiotic bifidobacterial species |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2602693A1 true CA2602693A1 (en) | 2006-11-23 |
Family
ID=34982549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002602693A Abandoned CA2602693A1 (en) | 2005-05-16 | 2006-03-31 | Probiotic bifidobacterial species |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7959912B2 (enExample) |
| EP (1) | EP1883695B1 (enExample) |
| JP (1) | JP2008539776A (enExample) |
| AT (1) | ATE432337T1 (enExample) |
| CA (1) | CA2602693A1 (enExample) |
| DE (1) | DE602006006997D1 (enExample) |
| DK (1) | DK1883695T3 (enExample) |
| ES (1) | ES2325887T3 (enExample) |
| WO (1) | WO2006122850A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1997907A1 (en) | 2007-06-01 | 2008-12-03 | Friesland Brands B.V. | Bifidobacteria |
| EP2203551B1 (en) * | 2007-10-20 | 2013-08-21 | Université de Liège | Bifidobacterial species |
| US9649380B2 (en) * | 2009-01-12 | 2017-05-16 | Pfizer Italia S.R.L. | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
| EP2338350B1 (en) * | 2009-12-24 | 2016-04-06 | CSK Food Enrichment B.V. | Fermented dairy product |
| RU2451734C2 (ru) * | 2010-05-14 | 2012-05-27 | Татьяна Александровна Левченко | ШТАММ Bifidobacterium adolescentis 79-82, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ |
| WO2011148220A1 (en) * | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving transepithelial resistance |
| RU2451735C2 (ru) * | 2010-05-28 | 2012-05-27 | Татьяна Александровна Левченко | ШТАММ Bifidobacterium adolescentis 79-84, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ |
| US9980501B2 (en) | 2014-12-26 | 2018-05-29 | Salah Mohammed Aleid | Method of making probiotic dairy products with date syrup additive |
| CN107653306B (zh) * | 2017-11-13 | 2020-05-08 | 江南大学 | 一种基于高通量测序的双歧杆菌快速检测方法及应用 |
| BE1028802B1 (fr) | 2020-11-16 | 2022-06-14 | Le Centre Wallon De Rech Agronomiques | Développement d'une composition symbiotique comme un additif d'alimentation pour les porcelets ou les truies gestantes pour moduler le microbiote intestinal des porcelets au temps du sevrage |
| IT202200022401A1 (it) * | 2022-10-31 | 2024-05-01 | Probionova Sa | Ceppi di batteri per il trattamento di disturbi urologici, loro composizioni e usi relativi |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1227152A1 (en) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bacterial strain and genome of bifidobacterium |
| US20030092163A1 (en) * | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
-
2006
- 2006-03-31 EP EP06725493A patent/EP1883695B1/en not_active Not-in-force
- 2006-03-31 ES ES06725493T patent/ES2325887T3/es active Active
- 2006-03-31 CA CA002602693A patent/CA2602693A1/en not_active Abandoned
- 2006-03-31 WO PCT/EP2006/061247 patent/WO2006122850A1/en not_active Ceased
- 2006-03-31 DE DE602006006997T patent/DE602006006997D1/de active Active
- 2006-03-31 US US11/914,434 patent/US7959912B2/en not_active Expired - Fee Related
- 2006-03-31 AT AT06725493T patent/ATE432337T1/de not_active IP Right Cessation
- 2006-03-31 JP JP2008511662A patent/JP2008539776A/ja active Pending
- 2006-03-31 DK DK06725493T patent/DK1883695T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE432337T1 (de) | 2009-06-15 |
| US20080274085A1 (en) | 2008-11-06 |
| DE602006006997D1 (de) | 2009-07-09 |
| DK1883695T3 (da) | 2009-07-20 |
| JP2008539776A (ja) | 2008-11-20 |
| WO2006122850A1 (en) | 2006-11-23 |
| EP1883695B1 (en) | 2009-05-27 |
| EP1883695A1 (en) | 2008-02-06 |
| US7959912B2 (en) | 2011-06-14 |
| ES2325887T3 (es) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parmjit | Fermented dairy products: starter cultures and potential nutritional benefits | |
| Jeong et al. | Characterization and antibacterial activity of a novel exopolysaccharide produced by Lactobacillus kefiranofaciens DN1 isolated from kefir | |
| CN1297653C (zh) | 包含戊糖乳杆菌菌株的组合物及其用途 | |
| KR101683474B1 (ko) | 과민성 대장 증후군 예방 또는 치료용 조성물 | |
| KR20200065004A (ko) | 클로스트리듐 디피실리 감염을 치료하기 위한 새로운 용도 | |
| JP2019001815A5 (enExample) | ||
| SE0402406D0 (sv) | Probiotic lactobacillus strains for improved vaginal health | |
| JP7193469B2 (ja) | 筋肉増量用組成物 | |
| TWI689585B (zh) | 新穎乳酸菌株及包含新穎乳酸菌株之免疫賦活劑 | |
| WO2000071138A3 (en) | Oral administration of lactobacillus for the maintenance of health in women | |
| ES2396501T3 (es) | Cepa de Lactobacillus delbrueckii que disminuye el colesterol en sangre | |
| WO2011050426A3 (en) | New strains of lactic acid bacteria and their combinations producing probiotic preparations | |
| ITMI20110793A1 (it) | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. | |
| CA2602693A1 (en) | Probiotic bifidobacterial species | |
| Ortu et al. | Identification and functional characterization of Lactobacillus strains isolated from milk and Gioddu, a traditional Sardinian fermented milk | |
| RU2010117248A (ru) | ПРИМЕНЕНИЕ ШТАММА Вifidobacterium ДЛЯ ПОЛУЧЕНИЯ КОМПОЗИЦИИ, ПРЕДНАЗНАЧЕННОЙ ДЛЯ ПРОФИЛАКТИКИ И/ИЛИ ЛЕЧЕНИЯ ПРОЯВЛЕНИЙ АЛЛЕРГИЧЕСКОГО ТИПА | |
| WO2011141762A1 (en) | Synergistic fermentation of lactobacillus rhamnosus and lactobacillus paracasei subsp paracasei | |
| Ghatani et al. | Assessment of probiotic characteristics of lactic acid bacteria isolated from fermented yak milk products of Sikkim, India: Chhurpi, Shyow, and Khachu | |
| EP3131562A1 (en) | Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after dysbiosis | |
| MXPA04004252A (es) | Del genero bifidobacterium y alimentos fermentados que utilizan la misma. | |
| EP3972619A1 (en) | Composition for treatment, alleviation or prophylaxis of acne | |
| JPWO2005092122A1 (ja) | ユッカ抽出物、キラヤ抽出物及び乳酸菌からなる組成物及び同組成物を含有する飲食品 | |
| CA2673195C (en) | Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria | |
| JP7362081B2 (ja) | 新規な乳酸菌株及びその用途 | |
| WO2014167995A1 (ja) | 免疫調節作用を有する乳酸菌のスクリーニング方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20191101 |